Strategy for When Satisfied Customers Don’t Come Back

Posted by Christopher Dent

Oct 21, 2016 9:14:53 AM

A month ago, my wife and I celebrated our third wedding anniversary. As we celebrated, I thought back to the autumn of 2007 when we first met.

I was a single 20-something professional, less than a year removed from active duty in the Marine Corps and anticipating settling down and starting a family. Having tried the “bar scene” to no avail, I decided to join eHarmony. Six months later, having met my beautiful wife and extremely happy with the outcome of my time on the site, I closed my account.

As I reminisced, I glanced at the pile of magazines sitting on the coffee table. I wondered: how does a company like eHarmony stay in business when a successful outcome means its clients never need it again, as opposed to other businesses (like periodicals) where the value proposition is ongoing?

Read More

Topics: Competitive Intelligence, Brand Insights, Technology/Telecomm, Competitive Strategy

Upcoming Event: Ken Sawka Speaking at BU Questrom Health & Life Sciences Conference October 14th

Posted by Fuld + Company

Oct 12, 2016 1:40:45 PM

On Friday, October 14th, Fuld + Company CEO, Ken Sawka, is speaking at the Boston University Questrom School of Business's fourth annual Health & Life Sciences Conference. 

The Health & Life Sciences Conference is an annual, student-organized event that brings together a diverse audience of more than 350 students and professionals across all sectors of the US healthcare industry for valuable networking and comprehensive programming spanning from healthcare delivery and hospitals to pharmaceuticals and medical devices.

Read More

Topics: Events, Healthcare, Life Sciences

Social Media Has Changed the Trajectory of Corporate Scandals

Posted by Christopher Dent

Sep 28, 2016 10:24:56 AM

There is an old rule of thumb that for every letter a congressman receives, there are 50 people thinking the same thing who didn’t pick up a pen. For every customer who bothers to complain, 26 others remain silent (and buy your competitor’s product instead).

How many people does a Facebook comment represent? What about a like or a share?

Read More

Topics: Brand Insights, Manufacturing/Industrial, Competitive Strategy

Upcoming Event: FGH Academy of Competitive Intelligence Certification Program Chicago October 31-Nov. 4, 2016

Posted by Fuld + Company

Sep 14, 2016 12:10:04 PM

 Join Leonard Fuld, Dr. Ben Gilad, Jan Herring, and Dr. Helen Rothberg, in Chicago October 31-November 4 for their core and advanced certification coursesYou will be engaged, excited, and a bit over whelmed by these dynamic presenters.

Read More

Topics: Competitive Intelligence, Events, FGH Academy of Competitive Intelligence, Fuld, Leonard

Is Amazon Becoming a Bank?

Posted by Ken Sawka

Aug 23, 2016 3:54:49 PM

UPDATE: Wells Fargo and Amazon ended their partnership on 08/31/2016 with minimal comment. The partnership fell under criticism from consumer advocates and organizations promoting affordable education.

Last month, entered the student loan business in a partnership with Wells Fargo, offering lower rates for student loans to Amazon customers who subscribe to the online retailer’s Prime Student service.  Wells Fargo will cut half a percentage point from its interest rate on student loans to Amazon Prime Student members, who also get benefits such as free two-day shipping and access to movies, TV shows, and online photo storage.

Does this deal signal what many have felt is the inevitable entry of technology companies into the financial services industry, or is it a convenient and mutually beneficial partnership between two companies with common interests?

Read More

Topics: Brand Insights, Financial Services, Market Analysis, Competitive Strategy

Upcoming Event: Robert Flynn Speaking at Pharma CI US Conference & Exhibition September 14th

Posted by Fuld + Company

Aug 23, 2016 9:19:47 AM

Join us this month at the Pharma CI Conference & Exhibition taking place September 13th - 14th at the Hilton Parsippany in Parsippany, New Jersey.

The Pharma CI Conference & Exhibition is the largest assembly of senior level pharmaceutical, biotech, and medical device professionals seeking the latest news and the chance to network with all the industry’s luminaries.

Members of our Life Sciences team will be at our booth to find out how we can address your competitive intelligence and strategy development needs in the pharmaceutical, biotech, medical device, and diagnostics industries. Robert Flynn, Principal, Strategic Accounts, will be giving a talk on early warning through scenario planning on Wednesday, September 14th.

Read More

Topics: Competitive Intelligence, Early Warning Monitoring, Fuld + Company, Pharma, Scenario Analysis

Medication-Induced Syndromes Offer Growth Opportunity

Posted by Kyle Nicholson

Aug 15, 2016 1:40:17 PM

Opioid-induced constipation, tardive dyskinesia, and other medication-induced syndromes present worthwhile revenue opportunities for pharmaceutical R&D.

In the 1960s, researchers discovered that the loss of motor control from Parkinson’s disease (PD) was tied to a deficiency of dopamine in a part of the brain involved in the coordination of movement.

Evidence soon established that administration of levodopa, a dopamine precursor molecule, dramatically improved PD symptoms. Here’s the catch: relief of symptoms was accompanied by severe nausea and vomiting. Levodopa was not only being converted to dopamine in the brain but also in the bloodstream, activating dopamine receptors in the peripheral nervous system and causing the adverse side effects.

Read More

Topics: Pharma, Life Sciences, Product Positioning, Competitive Strategy

Can Apple TV Outshine Netflix and Traditional TV Broadcasters?

Posted by Ken Sawka

Aug 3, 2016 11:41:11 AM

Apple has long been expected to “revolutionize” how we watch television.  Ever since it launched Apple TV in 2006, speculation has been rife that Apple would become a major force in video production and distribution.

Apple’s refresh of Apple TV last year - improving voice search with Siri and adding a bunch more apps - did little to quell that speculation.

Read More

Topics: Brand Insights, Innovation, Market Analysis, Technology/Telecomm, Product Positioning, Competitive Strategy

Teva Membership in PhRMA Benefits Brand-Name Pharma

Posted by Steve Ames

Jul 12, 2016 10:53:02 AM

Teva, the world’s largest producer of generic medications, recently requested membership into Pharmaceutical Research and Manufacturers of America (PhRMA), the powerful US trade association of brand-name medicine manufacturers.

PhRMA is a lobby powerhouse, largely due to representation from most of the biggest players in the pharmaceutical industry. As detailed in the New York Times, Teva’s request ruffled the feathers of some PhRMA members who see Teva (and other generics companies) as a threat to the success of branded medicine. Brand-name and generic drug companies are no strangers to court battles against each other, typically around brand patent validity and timelines for generic entrance.

Read More

Topics: Innovation, Pharma, Life Sciences, Competitive Strategy

Of Course Nobody Saw Brexit or Donald Trump Coming

Posted by Ken Sawka

Jul 6, 2016 2:22:24 PM

I recently ran a scenario-based strategic planning engagement with a European online entertainment company. In it, we created five future, plausible scenarios that described what the external operating environment could look like for our client in the next five to seven years. 

In one scenario, the global entertainment industry underwent massive consolidation as technological advances enabled cheap, on-demand entertainment of all sorts that provided the largest entertainment companies an incredible opportunity. In another, trade wars broke out restricting the free flow of intellectual property, leading to a proliferation of “black market” entertainment operations in which shady operators offered products based on questionable access to content. 

Read More

Topics: Competitive Intelligence, Scenario Analysis, Competitive Strategy

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.